Pharma Journalist 8801 posts 0 comments

SMi Reports: Interactive workshop overview for SMi's 22nd Annual Superbugs & Superdrugs Conference, London in March 2020 SMi’s highly anticipated 22nd Annual Superbugs &…
Read More...

PPD, Inc. (PPD) has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval…
Read More...

Almirall, S.A. and WuXi Biologics have announced the signing of an agreement. Through this collaboration Almirall embarks on its strategy to develop highly innovative biologic products…
Read More...

Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing therapies to enable healthier lives, today announce…
Read More...

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection) 100 u/mL for use as a new mealtime insulin option for children with…
Read More...

Galen announced the completion of a multi-million pound acquisition and takeover of boutique healthcare company, POA Pharma. The move enables Galen to significantly expand its global…
Read More...

Almirall, S.A. (ALM) has announced  the execution of an option agreement to acquire Bioniz Therapeutics, Inc. a clinical stage biopharmaceutical company based in Irvine, California,…
Read More...

ProBioGen AG has signed a commercial license agreement with Roche for applying ProBioGen’s proprietary GlymaxX technology to boost the antibody’s ADCC anti-tumor activity. The…
Read More...

5 QUESTIONS FOR LAB LEADERS Ahead of our Smartlab Exchanges in Berlin & Florida we sat down with 8 leading Lab experts to hear their unique insights and advice on the challenges…
Read More...

Incyte announced the validation of the Company’s Marketing Authorization Application (MAA) for pemigatinib for the treatment of adults with locally advanced or metastatic…
Read More...